Suvretta Capital Management as of March 31, 2021
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 106 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adobe Systems Incorporated (ADBE) | 4.4 | $301M | 633k | 475.37 | |
| Lauder Estee Cos Cl A (EL) | 3.5 | $240M | 824k | 290.85 | |
| Amazon (AMZN) | 3.5 | $240M | 77k | 3094.08 | |
| Uber Technologies (UBER) | 3.4 | $230M | 4.2M | 54.51 | |
| Tapestry (TPR) | 3.3 | $222M | 5.4M | 41.21 | |
| McDonald's Corporation (MCD) | 3.2 | $214M | 955k | 224.14 | |
| Dollar General (DG) | 3.1 | $212M | 1.0M | 202.62 | |
| Walt Disney Company (DIS) | 3.1 | $212M | 1.1M | 184.52 | |
| UnitedHealth (UNH) | 3.0 | $206M | 553k | 372.07 | |
| Union Pacific Corporation (UNP) | 3.0 | $201M | 913k | 220.41 | |
| Otis Worldwide Corp (OTIS) | 2.9 | $197M | 2.9M | 68.45 | |
| Rh (RH) | 2.8 | $186M | 312k | 596.60 | |
| Paysafe Ord | 2.6 | $176M | 13M | 13.50 | |
| Mastercard Incorporated Cl A (MA) | 2.5 | $169M | 475k | 356.05 | |
| Iqvia Holdings (IQV) | 2.4 | $163M | 843k | 193.14 | |
| Medtronic SHS (MDT) | 2.4 | $161M | 1.4M | 118.13 | |
| Gfl Environmental Sub Vtg Shs (GFL) | 2.4 | $159M | 4.5M | 34.95 | |
| Five Below (FIVE) | 2.3 | $153M | 800k | 190.79 | |
| Anaplan | 2.2 | $147M | 2.7M | 53.85 | |
| Nike CL B (NKE) | 2.1 | $143M | 1.1M | 132.89 | |
| Nxp Semiconductors N V (NXPI) | 2.1 | $141M | 700k | 201.34 | |
| KBR (KBR) | 2.0 | $135M | 3.5M | 38.39 | |
| Ross Stores (ROST) | 2.0 | $134M | 1.1M | 119.91 | |
| Snap Cl A (SNAP) | 1.9 | $126M | 2.4M | 52.29 | |
| Carvana Cl A (CVNA) | 1.9 | $125M | 478k | 262.40 | |
| Opendoor Technologies (OPEN) | 1.7 | $118M | 5.6M | 21.19 | |
| EXACT Sciences Corporation (EXAS) | 1.7 | $117M | 887k | 131.78 | |
| Catalent | 1.6 | $105M | 1.0M | 105.31 | |
| Pinterest Cl A (PINS) | 1.5 | $105M | 1.4M | 74.03 | |
| AmerisourceBergen (COR) | 1.5 | $103M | 874k | 118.07 | |
| Quanta Services (PWR) | 1.5 | $100M | 1.1M | 87.98 | |
| Square Cl A (XYZ) | 1.3 | $91M | 401k | 227.05 | |
| Te Connectivity Reg Shs | 1.3 | $89M | 691k | 129.11 | |
| Guardant Health (GH) | 1.3 | $86M | 562k | 152.65 | |
| Fidelity National Information Services (FIS) | 1.2 | $84M | 600k | 140.61 | |
| Farfetch Ord Sh Cl A (FTCHQ) | 1.0 | $71M | 1.3M | 53.02 | |
| Jaws Acquisition Corp SHS | 1.0 | $66M | 5.0M | 13.25 | |
| Agios Pharmaceuticals (AGIO) | 0.8 | $56M | 1.1M | 51.64 | |
| Invitae (NVTAQ) | 0.8 | $54M | 1.4M | 38.21 | |
| Royalty Pharma Shs Class A (RPRX) | 0.6 | $42M | 957k | 43.62 | |
| Global Payments (GPN) | 0.6 | $42M | 207k | 201.58 | |
| Bumble Com Cl A (BMBL) | 0.6 | $40M | 644k | 62.38 | |
| Bluebird Bio | 0.6 | $39M | 1.3M | 30.15 | |
| Gores Holdings Vi Com Cl A | 0.6 | $38M | 2.8M | 13.70 | |
| Foley Trasimene Acquistn Cor Com Cl A | 0.5 | $36M | 3.6M | 10.04 | |
| Intra Cellular Therapies (ITCI) | 0.5 | $35M | 1.0M | 33.93 | |
| Solid Biosciences | 0.5 | $33M | 6.0M | 5.53 | |
| Social Capital Hedosopha Hld Shs Cl A Put Option | 0.4 | $30M | 1.8M | 17.15 | |
| Finserv Acquisition Corp Cl A | 0.4 | $30M | 2.3M | 13.10 | |
| Sutro Biopharma | 0.4 | $29M | 1.3M | 22.76 | |
| Marinus Pharmaceuticals Com New | 0.4 | $28M | 1.8M | 15.48 | |
| Revolution Accelertn Acqu Com Cl A | 0.4 | $25M | 2.5M | 10.14 | |
| Terns Pharmaceuticals (TERN) | 0.4 | $25M | 1.1M | 22.00 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $25M | 960k | 25.69 | |
| Sana Biotechnology (SANA) | 0.3 | $22M | 668k | 33.47 | |
| Ajax I Cl A Ord | 0.3 | $22M | 2.2M | 10.26 | |
| Mereo Biopharma Group Ads (MREO) | 0.3 | $22M | 6.4M | 3.37 | |
| Kura Oncology (KURA) | 0.3 | $21M | 732k | 28.27 | |
| Forte Biosciences | 0.3 | $21M | 600k | 34.27 | |
| Lyft Cl A Com (LYFT) | 0.3 | $19M | 300k | 63.18 | |
| Fulcrum Therapeutics (FULC) | 0.3 | $18M | 1.5M | 11.78 | |
| Gemini Therapeutics | 0.3 | $18M | 1.3M | 13.55 | |
| Take-Two Interactive Software (TTWO) | 0.2 | $15M | 87k | 176.70 | |
| Deciphera Pharmaceuticals | 0.2 | $15M | 337k | 44.84 | |
| Metromile | 0.2 | $14M | 1.4M | 10.29 | |
| Sio Gene Therapies Common | 0.2 | $14M | 5.5M | 2.61 | |
| Bolt Biotherapeutics | 0.2 | $14M | 420k | 32.91 | |
| Inflarx Nv (IFRX) | 0.2 | $13M | 3.3M | 3.90 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $12M | 1.2M | 10.16 | |
| Therapeutics Acquisition Cor Com Cl A | 0.2 | $11M | 1.1M | 10.51 | |
| Neximmune | 0.2 | $11M | 579k | 19.08 | |
| Finserv Acquisition Corp Ii Unit 02/17/2026 | 0.2 | $11M | 1.1M | 9.97 | |
| Aeglea Biotherapeutics | 0.2 | $11M | 1.4M | 7.92 | |
| Prometheus Biosciences | 0.2 | $11M | 579k | 18.26 | |
| Alussa Energy Acquisition Shs Cl A | 0.1 | $10M | 1.0M | 10.00 | |
| Chimerix (CMRX) | 0.1 | $8.8M | 915k | 9.64 | |
| Chinook Therapeutics | 0.1 | $8.5M | 550k | 15.54 | |
| Kezar Life Sciences | 0.1 | $8.4M | 1.4M | 5.96 | |
| Heron Therapeutics (HRTX) | 0.1 | $8.2M | 506k | 16.21 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $7.9M | 440k | 17.90 | |
| Newhold Investment Corp Com Cl A | 0.1 | $7.5M | 750k | 10.01 | |
| Inozyme Pharma (INZY) | 0.1 | $6.8M | 341k | 19.80 | |
| Otonomy | 0.1 | $5.3M | 2.1M | 2.55 | |
| Research Alliance Corp Ii Com Cl A | 0.1 | $5.1M | 500k | 10.25 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $4.9M | 851k | 5.79 | |
| Fs Development Corp Ii Com Cl A | 0.1 | $4.0M | 400k | 9.96 | |
| Adagene Ads (ADAG) | 0.1 | $3.7M | 204k | 17.95 | |
| European Biotech Acqutn Corp Unit 03/09/2026 | 0.0 | $3.0M | 300k | 10.07 | |
| Healthcor Catalio Acqu Corp Cl A Shs | 0.0 | $3.0M | 300k | 10.00 | |
| Decibel Therapeutics | 0.0 | $3.0M | 264k | 11.36 | |
| Omega Alpha Spac Cl A | 0.0 | $3.0M | 300k | 9.90 | |
| Jaws Acquisition Corp *w Exp 99/99/999 | 0.0 | $2.1M | 675k | 3.18 | |
| Bcls Acquisition Corp Com Cl A | 0.0 | $2.1M | 200k | 10.57 | |
| Turmeric Acquisition Corp Cl A | 0.0 | $2.0M | 200k | 9.77 | |
| Diversey Hldgs Ord Shs | 0.0 | $1.6M | 107k | 14.71 | |
| Foley Trasimene Acquistn Cor *w Exp 05/26/202 | 0.0 | $1.2M | 774k | 1.60 | |
| Foghorn Therapeutics (FHTX) | 0.0 | $1.1M | 84k | 13.18 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.0M | 100k | 10.47 | |
| Eucrates Biomedical Acqu Cor SHS | 0.0 | $998k | 100k | 9.98 | |
| Frazier Lifesciences Acqu Cl A Shs | 0.0 | $871k | 88k | 9.95 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.0 | $560k | 50k | 11.20 | |
| Helix Acquisition Corp Com Cl A | 0.0 | $361k | 35k | 10.21 | |
| Arya Sciences Acquisition Com Cl A | 0.0 | $204k | 15k | 13.75 | |
| Turmeric Acquisition Corp *w Exp 10/08/202 | 0.0 | $67k | 67k | 1.00 | |
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $42k | 33k | 1.26 | |
| Frazier Lifesciences Acqu *w Exp 11/30/202 | 0.0 | $26k | 29k | 0.89 |